−2.8680USD
−245.60 MUSD
84.20 M
About Rocket Pharmaceuticals, Inc.
Sector
Industry
CEO
Gaurav D. Shah
Website
Headquarters
Cranbury
Employees (FY)
268
Founded
1999
FIGI
BBG01BYF7LK7
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
